share_log

Cardio Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer Dogan Meeshanthini

SEC announcement ·  Feb 22 03:56
Summary by Futu AI
Cardio Diagnostics Holdings, Inc. (CDIO.US) has reported a transaction by Chief Executive Officer Dogan Meeshanthini on January 23, 2024. The details of the transaction, including the number of shares involved and the transaction price, have not been disclosed in the announcement. The action type and status, as well as the number of shares held by Meeshanthini after the transaction, remain unspecified. Investors are advised to monitor further disclosures for complete transaction details.
Cardio Diagnostics Holdings, Inc. (CDIO.US) has reported a transaction by Chief Executive Officer Dogan Meeshanthini on January 23, 2024. The details of the transaction, including the number of shares involved and the transaction price, have not been disclosed in the announcement. The action type and status, as well as the number of shares held by Meeshanthini after the transaction, remain unspecified. Investors are advised to monitor further disclosures for complete transaction details.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.